Brief: Medexus Announces Record Fiscal Q1 2023 Revenue Of Us$23.0 Million, A 33% Increase Versus Fiscal Q1 2022

Medexus Pharmaceuticals

08/08/2022 23:05

Aug 8 (Reuters) - Medexus Pharmaceuticals Inc  MDP.TO :
    * MEDEXUS ANNOUNCES RECORD FISCAL Q1 2023 REVENUE OF US$23.0
MILLION, A 33% INCREASE VERSUS FISCAL Q1 2022
    * MEDEXUS PHARMACEUTICALS INC - TREOSULFAN NDA RESUBMITTED
TO FDA,
REGULATORY MILESTONE PAYMENTS DEFERRED TO OCTOBER 2023
    * MEDEXUS PHARMACEUTICALS INC - TOTAL REVENUE OF $23.0
MILLION IN
FISCAL Q1 2023, AN INCREASE OF 33% COMPARED TO $17.3 MILLION IN
FISCAL Q1 2022
    * MEDEXUS PHARMACEUTICALS INC - NET LOSS OF $1.4 MILLION IN
FISCAL
Q1 2023, A $5.2 MILLION IMPROVEMENT COMPARED TO $6.6 MILLION IN
FISCAL Q1 2022.

Source text for Eikon:  ID:nGNX6pdFH 
Further company coverage:  MDP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))